Načítá se...
Unprecedented inhibition of P-gp activity by a novel rutheniumcyclopentadienyl compound bearing a bipyridine-biotin ligand
Two new ruthenium complexes, [Ru(η(5)-Cp)(PPh(3))(2,2’-bipy-4,4’-R)](+) with R = CH(2)OH (Ru1) or dibiotin ester (Ru2) were synthesized and fully characterized. Both compounds were tested against two types of breast cancer cells (MCF7 and MDA-MB231), showing better cytotoxicity than cisplatin in the...
Uloženo v:
| Vydáno v: | Eur J Med Chem |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2018
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6345558/ https://ncbi.nlm.nih.gov/pubmed/30579125 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejmech.2018.12.022 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|